1. Home
  2. EVOK vs UGRO Comparison

EVOK vs UGRO Comparison

Compare EVOK & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • UGRO
  • Stock Information
  • Founded
  • EVOK 2007
  • UGRO 2014
  • Country
  • EVOK United States
  • UGRO United States
  • Employees
  • EVOK N/A
  • UGRO N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • UGRO Industrial Specialties
  • Sector
  • EVOK Health Care
  • UGRO Consumer Discretionary
  • Exchange
  • EVOK Nasdaq
  • UGRO Nasdaq
  • Market Cap
  • EVOK 7.1M
  • UGRO 8.8M
  • IPO Year
  • EVOK 2013
  • UGRO N/A
  • Fundamental
  • Price
  • EVOK $3.70
  • UGRO $0.80
  • Analyst Decision
  • EVOK
  • UGRO Strong Buy
  • Analyst Count
  • EVOK 0
  • UGRO 2
  • Target Price
  • EVOK N/A
  • UGRO $3.13
  • AVG Volume (30 Days)
  • EVOK 11.2K
  • UGRO 47.6K
  • Earning Date
  • EVOK 03-13-2025
  • UGRO 04-29-2025
  • Dividend Yield
  • EVOK N/A
  • UGRO N/A
  • EPS Growth
  • EVOK N/A
  • UGRO N/A
  • EPS
  • EVOK N/A
  • UGRO N/A
  • Revenue
  • EVOK $8,617,036.00
  • UGRO $59,985,133.00
  • Revenue This Year
  • EVOK $97.35
  • UGRO $2.17
  • Revenue Next Year
  • EVOK $99.52
  • UGRO $27.19
  • P/E Ratio
  • EVOK N/A
  • UGRO N/A
  • Revenue Growth
  • EVOK 100.35
  • UGRO N/A
  • 52 Week Low
  • EVOK $3.44
  • UGRO $0.60
  • 52 Week High
  • EVOK $12.32
  • UGRO $2.42
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 32.70
  • UGRO 47.69
  • Support Level
  • EVOK $3.68
  • UGRO $0.78
  • Resistance Level
  • EVOK $4.22
  • UGRO $0.85
  • Average True Range (ATR)
  • EVOK 0.44
  • UGRO 0.06
  • MACD
  • EVOK -0.13
  • UGRO 0.01
  • Stochastic Oscillator
  • EVOK 13.98
  • UGRO 62.33

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

Share on Social Networks: